← GRAIL-HCC home · Evidence map v10
🧬

GRAIL-HCC Evidence Map

Living evidence and gap map · v10 · 851 meta-analyses · search Jan 2010–Mar 2026

🔍
⚠ Note. The volume of evidence (number of meta-analyses) shows density, not quality. AMSTAR 2 appraisal is in progress. Data are those of the GRAIL-HCC article (Supplementary Data S1), extracted by a team of 11 extractors and harmonised with scripted checks. Repository living: updated annually at first, then every six months.
Showing 0 of 0 meta-analyses
Study MTH index Comparison Type Outcomes AMSTAR-2

GRAIL-HCC Working Groups

More than 90 Italian investigators · nine thematic working groups

With the unconditional support of

Roche AstraZeneca

GRAIL-HCC is an independent research initiative of DISCOG, University of Padua. Industry support is unconditional and does not influence the selection, analysis or presentation of the evidence.